We take a proactive, holistic, and consultative approach to understand your product, goals, and the myriad of variables between where you are and where you want to be.
In today’s increasingly complex world of drug development, we’re moving beyond the traditional phased approach of shepherding a product from concept to compound to cure. We harness a vast array of capabilities and services, all under the unified strategy of our drug development experts, to custom-build and deliver a solution that maximizes your chance at success.
Long story short: the best way to get started is to have a conversation with us. Help us understand the question you’re trying to solve, and we’ll take it from there.
Integrated Drug Development Solutions
Over the last 40 years, we’ve built up our world-class ecosystem of expertise and capabilities to offer you an end-to-end solution to get your product from concept to compound to cure. We’ve seen—and done—it all. We’ve earned the knowledge that empowers us to proactively prevent common challenges and unexpected hurdles that could get in-between you and successful outcomes. No matter where you are in your product lifecycle, our Integrated Drug Development Solutions will partner with you to safely and effectively guide you to success.
Early Phase Solutions
We understand the need to maximize success while minimizing time and costs. That’s why we strategically positioned our laboratories within close…
Early Patient Solutions
We provide the infrastructure, technologies, and expertise required to execute early phase patient studies worldwide.
Phase I healthy volunteer studies play a vital role in clinical research by providing researchers with the knowledge they need to make educated…
We support the phase II-III clinical development of niche treatments, blockbuster drugs, and biosimilars that help save lives.
Our Embedded Solutions™ model is the most transparent, integrated, and client-centric solution in the industry. As industry pioneers and consultative experts, we provide the strategic guidance and confidential input needed to solve your specific drug development and resourcing challenges. Our therapeutic and operational experts are fully integrated into your existing operating model and culture while you maintain full strategic control of the development process. This helps eliminate the cumbersome and costly inefficiencies associated with internal drug development teams and the traditional CRO model.
We are a dynamic team of experts in drug research that deliver unique, customized solutions for your specific needs.
Biometrics forms a centralized, global model that integrates Portfolio Management, Biostatistics & Programming, Data Operations, and Medical Writing & Publishing.
Our Biometrics organization starts with the end in mind, tracking backward along the regulatory pathway to ensure the data are reported, displayed and captured in the most appropriate manner.
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
COVID-19 Impact on Rare Disease Clinical Trials
Rare disease patient organizations are coping with a broad range of other organizational challenges, including reduced funding, canceled fundraising…
The Impact Of Contraceptive Requirements On Pediatric Clinical Trials
Contraceptive requirements applied to women of child-bearing potential participating in clinical trials also apply to children participating in…